If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vittorio Montefusco is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 61 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 103 Article
  • 4 Review article
  • 2 Conference contribution
  • 1 Comment/debate

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

Montefusco, V., Corso, A., Galli, M., Ardoino, I., Pezzatti, S., Carniti, C., Patriarca, F., Gherlinzoni, F., Zambello, R., Sammassimo, S., Marcatti, M., Nozza, A., Crippa, C., Cafro, A. M., Baldini, L. & Corradini, P., 2020, In : British Journal of Haematology. 188, 6, p. 907-917 11 p.

Research output: Contribution to journalArticle

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

Montefusco, V., Corso, A., Galli, M., Ardoino, I., Pezzatti, S., Carniti, C., Patriarca, F., Gherlinzoni, F., Zambello, R., Sammassimo, S., Marcatti, M., Nozza, A., Crippa, C., Cafro, A. M., Baldini, L. & Corradini, P., Jan 1 2020, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

  • Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs

    Montefusco, V., Gay, F., Spada, S., de Paoli, L., Raimondo, F. D., Ribolla, R., Musolino, C., Patriarca, F., Musto, P., Galieni, P., Ballanti, S., Nozzoli, C., Cascavilla, N., Ben-Yehuda, D., Nagler, A., Hajek, R., Offidani, M., Liberati, A. M., Sonneveld, P., Cavo, M. & 2 others, Corradini, P. & Boccadoro, M., 2020, In : Haematologica. 105, 1, p. 193-200 8 p.

    Research output: Contribution to journalArticle

    First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials

    Larocca, A., Mina, R., Offidani, M., Liberati, A. M., Ledda, A., Patriarca, F., Evangelista, A., Spada, S., Benevolo, G., Oddolo, D., Innao, V., Cangialosi, C., Bernardini, A., Musto, P., Amico, V., Fraticelli, V., Paris, L., Giuliani, N., Falcone, A. P., Zambello, R. & 7 others, De Paoli, L., Romano, A., Palumbo, A., Montefusco, V., Hajek, R., Boccadoro, M. & Bringhen, S., Jun 27 2019, In : Haematologica.

    Research output: Contribution to journalArticle

  • Ocular disorders in multiple myeloma patients: cross-sectional study of prevalence and association with treatment

    Pennisi, M., Berchicci, L., Miserocchi, E., Mussetti, A., Cacioppo, V., David, A., Scialdone, A., Lorusso, I., Modorati, G., Corradini, P. & Montefusco, V., Jan 28 2019, In : Leukemia and Lymphoma. 60, 2, p. 477-482 6 p.

    Research output: Contribution to journalArticle